MedTrace Logo

Clinical and Radiographic Outcomes of TLIF w/3D Printed Cellular Implant

NCT05023733 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-01-28

No results posted yet for this study

Summary

This study is designed to evaluate clinical outcomes and spine fusion rates for patients undergoing transforaminal lumbar interbody fusion using the CONDUIT 3D printed titanium TLIF cage.

Conditions

  • Foraminal Stenosis
  • Degenerative Disc Disease
  • Lumbar Spondylolisthesis
  • Lumbar Spinal Stenosis

Interventions

DEVICE

CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium®

Patients undergoing 1-2 contiguous levels of interbody fixation from a transforaminal approach for spinal segments L2-S1

Sponsors & Collaborators

  • DePuy Synthes

    collaborator INDUSTRY

  • Farhan Karim

    lead OTHER

Principal Investigators

  • Farhan Karim, DO · Hartford Hospital; Hartford Healthcare Bone & Joint Institute

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2025-03-01
Completion
2025-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05023733 on ClinicalTrials.gov